Pharming Group's total assets for Q3 2024 were €425.51M, an increase of 2.30% from the previous quarter. PHAR total liabilities were €199.72M for the fiscal quarter, a -3.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.